A = 91.0-94.9
A- = 88.0-90.9
B+ = 85.0-87.9
B = 81.0-84.9
B- = 78.0-80.9
C = 71.0-74.9
C- = 68.0-70.9
D+ = 65.0-67.9
D = 61.0-64.9
D- = 58.0-60.9
F = <58.0
Category average: 81.4
Software average: 82.4
Company/solution |
Overall performance score (100-point scale) |
Trend (2020-2021) |
Total evaluations |
Culture
|
Loyalty
|
Operations
|
Product
|
Relationship
|
Value
|
|
Bluesight
Kit Check Bluesight for Controlled Substances |
90.0 |
0%
|
n=39
|
B+
|
A
|
A-
|
B+
|
A-
|
A
|
|
|
|
|
|
|
||||||
Omnicell
Analytics |
69.7 |
0%
|
n=25
|
D+
|
C-
|
C
|
C
|
C
|
D
|
|
|
|
|
|
|
||||||
Bluesight
Medacist RxAuditor |
68.9 |
0%
|
n=21
|
B-
|
F
|
C
|
D
|
C+
|
C+
|
|
50.0 |
100.0 |
Analytics
Medacist RxAuditor
Company/solution |
Overall performance score (100-point scale) |
Total evaluations |
Culture
|
Loyalty
|
Operations
|
Product
|
Relationship
|
Value
|
HelioMetrics
Drug Diversion Analytics * L |
76.5 |
n=9
|
C-
|
C+
|
C
|
C+
|
B-
|
B
|
|
|
|
|
|
||||
Imprivata
FairWarning Drug Diversion Monitoring * L |
93.9 |
n=13
|
A+
|
A+
|
A-
|
A-
|
A
|
A+
|
|
|
|
|
|
||||
Wolters Kluwer
Invistics Flowlytics * L |
80.2 |
n=6
|
C
|
B
|
C+
|
C+
|
A-
|
B+
|
Drug Diversion Analytics * L
n=9
FairWarning Drug Diversion Monitoring * L
n=13
Invistics Flowlytics * L
n=6